<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9500169</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20475</journal-id>
<journal-id journal-id-type="nlm-ta">Neurobiol Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurobiol. Dis.</journal-id>
<journal-title-group>
<journal-title>Neurobiology of disease</journal-title>
</journal-title-group>
<issn pub-type="ppub">0969-9961</issn>
<issn pub-type="epub">1095-953X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31927143</article-id>
<article-id pub-id-type="pmc">7027994</article-id>
<article-id pub-id-type="doi">10.1016/j.nbd.2020.104740</article-id>
<article-id pub-id-type="manuscript">NIHMS1068748</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Fragile X Syndrome and associated disorders: clinical aspects and pathology</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Salcedo-Arellano</surname>
<given-names>Maria Jimena</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dufour</surname>
<given-names>Brett</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McLennan</surname>
<given-names>Yingratana</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martinez-Cerdeno</surname>
<given-names>Veronica</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hagerman</surname>
<given-names>Randi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Pediatrics, University of California Davis School of Medicine, Sacramento, CA, USA</aff>
<aff id="A2"><label>2</label>Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis, Sacramento, CA, USA</aff>
<aff id="A3"><label>3</label>Institute for Pediatric Regenerative Medicine and Shriners Hospitals for Children Northern California, Sacramento, CA, USA</aff>
<aff id="A4"><label>4</label>Department of Pathology and Laboratory Medicine, UC Davis School of Medicine, Sacramento, CA, USA</aff>
<author-notes>
<corresp id="CR1"><bold>Corresponding author:</bold> Randi Hagerman, MD, MIND Institute UCDHS, 2825 50<sup>th</sup> Street, Sacramento, California, 95817, <email>rjhagerman@ucdmc.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>9</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>3</month>
<year>2020</year>
</pub-date>
<volume>136</volume>
<fpage>104740</fpage>
<lpage>104740</lpage>
<!--elocation-id from pubmed: 10.1016/j.nbd.2020.104740-->
<abstract id="ABS1">
<p id="P1">This review aims to assemble many years of research and clinical experience in the fields of neurodevelopment and neuroscience to present an up-to-date understanding of the clinical presentation, molecular and brain pathology associated with Fragile X syndrome, a neurodevelopmental condition that develops with the full mutation of the <italic>FMR1</italic> gene, located in the q27.3 loci of the X chromosome, and Fragile X-associated tremor/ataxia syndrome a neurodegenerative disease experienced by aging premutation carriers of the <italic>FMR1</italic> gene. It is important to understand that these two syndromes have a very distinct clinical and pathological presentation while sharing the same origin: the mutation of the <italic>FMR1</italic> gene; revealing the complexity of expansion genetics.</p>
</abstract>
<kwd-group>
<kwd>Fragile X syndrome</kwd>
<kwd>Fragile X-associated tremor/ataxia syndrome</kwd>
<kwd>FXTAS</kwd>
<kwd><italic>FMR1</italic> gene</kwd>
<kwd>neuropathology</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>